Pancreatic tumor cells can recruit Myeloid-derived suppressive cells (MDSCs) in the pancreatic TME by means of the production of the granulocyte-macrophage colony-stimulating factor (GM-CSF) [17,18]. The gene discussed is CSF2; the disease is pancreatic neoplasm.